What is OptionOne?
OptionOne operates as a specialized pharmacy provider, focusing on the delivery of home and alternate-site infusion therapies. The company distinguishes itself through a comprehensive clinical approach, offering personalized support for patients managing complex health issues such as Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, and various immune deficiencies. By integrating pharmacy services with ambulatory infusion centers and dedicated nursing support, the firm ensures that patients receive high-quality, compliant care outside of traditional hospital environments.
The company's market position is defined by its commitment to the Accreditation Commission for Health Care (ACHC) standards, which serves as a benchmark for its pharmacy and nursing operations. This focus on quality assurance allows OptionOne to effectively manage the logistics of total parenteral nutrition and IV antibiotic treatments, addressing a vital need in the continuum of patient care.
How much funding has OptionOne raised?
OptionOne has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in OptionOne
PPP
Public-Private Partnership
What's next for OptionOne?
Looking ahead, the strategic deployment of this capital will likely focus on enhancing the company's clinical reach and technological capabilities. As the demand for home-based infusion services continues to rise, OptionOne is poised to leverage its recent financing to optimize its supply chain and expand its network of ambulatory infusion centers. The focus remains on maintaining high-touch monitoring standards while scaling operations to meet the needs of a broader patient demographic.
Furthermore, the company is expected to invest in advanced patient management systems to streamline the delivery of chronic disease treatments. By strengthening its clinical infrastructure, OptionOne aims to improve patient outcomes and reinforce its competitive advantage in the specialty pharmacy landscape, ensuring long-term sustainability and growth in the evolving healthcare market.
